Despite its central importance to the application of the federal anti-kickback statute, 42 U.S.C. § 1320a-7b(b) (AKS), the term “refer” is not defined by statute or regulation, and it has seldom been interpreted by the courts...more
On November 16, 2020, the Office of Inspector General of the Department of Health and Human Services (OIG) issued a Special Fraud Alert addressing the fraud and abuse risks of speaker programs that are commonplace in the...more
11/20/2020
/ Anti-Kickback Statute ,
Enforcement Actions ,
Fair Market Value ,
False Claims Act (FCA) ,
FDA Approval ,
Fraud ,
Health Care Providers ,
Medical Devices ,
OIG ,
Pharmaceutical Industry ,
Speaker Programs